NEW YORK (GenomeWeb News) – The Europen Union awarded the CE Mark to Celera Genomics' hepatitis C virus genotyping test, parent Applera said today.
 
Celera developed the RealTime HCV Genotype Assay with Abbott. It will be sold as part of this alliance. The test is designed to be used on Applied Biosystems' PRISM 7000 PCR system.
 
Called the Abbott RealTime HCV Genotype test, it complements the HCV quantitative viral load test available on Abbott’s m2000 system.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.